These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19545653)

  • 21. [Kidney transplantation from a nephrological-urological viewpoint--results and problems. 2. Diagnosis and therapy after transplantation, complications, long-term results].
    Schulz W; Chlepas S; Heidler R; Pilgrim R; Seybold D; Sigel A; Gessler U
    Fortschr Med; 1977 Dec; 95(47-48):2813-8. PubMed ID: 338452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of cyclosporine in the development of immunosuppressive therapy.
    Chaverri C
    Transplant Proc; 2004 Mar; 36(2 Suppl):80S-82S. PubMed ID: 15041312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Donor reactive regulatory T cells.
    Feng G; Chan T; Wood KJ; Bushell A
    Curr Opin Organ Transplant; 2009 Aug; 14(4):432-8. PubMed ID: 19448539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New frontiers in heart transplantation. Clinical applications of basic research and new surgical approaches.
    Costanzo MR; Franco KL
    Cardiol Clin; 1995 Feb; 13(1):101-9. PubMed ID: 7796424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I study of high-stringency CD8 depletion of donor leukocyte infusions after allogeneic hematopoietic stem cell transplantation.
    Orti G; Lowdell M; Fielding A; Samuel E; Pang K; Kottaridis P; Morris E; Thomson K; Peggs K; Mackinnon S; Chakraverty R
    Transplantation; 2009 Dec; 88(11):1312-8. PubMed ID: 19996931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of living donor liver transplant patients using twice-daily 4-hour intravenous cyclosporine therapy.
    Sato K; Iwane T; Sekiguchi S; Nakamura A; Akamatsu Y; Kawagishi N; Miyagi S; Takeda I; Sato A; Fujimori K; Satomi S
    Transplant Proc; 2009; 41(1):229-32. PubMed ID: 19249521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Transplantation surgery and immunology: from origins to new paradigms of immune tolerance].
    Reding R
    Bull Mem Acad R Med Belg; 2002; 157(10-12):439-44; discussion 444-7. PubMed ID: 12854184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New therapeutic targets for antibodies and recombinant proteins in organ transplantation].
    Charpentier B
    Bull Acad Natl Med; 2008 May; 192(5):883-93; discussion 893-4. PubMed ID: 19238779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal transplantation: evolution in immunosuppression protocols.
    Pirenne J; Kawai M
    Curr Opin Organ Transplant; 2009 Jun; 14(3):250-5. PubMed ID: 19373085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of accelerated acute rejection after ABO-compatible living unrelated kidney transplantation.
    Matsuo N; Yamamoto H; Kobayashi A; Yamamoto I; Mitome J; Maruyama Y; Hayakawa H; Miyazaki Y; Utsunomiya Y; Hosoya T; Yamaguchi Y
    Clin Transplant; 2009 Aug; 23 Suppl 20():23-6. PubMed ID: 19594591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tolerance, xenotransplantation: future therapies.
    Weiss MJ; Ng CY; Madsen JC
    Surg Clin North Am; 2006 Oct; 86(5):1277-96, viii. PubMed ID: 16962414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of delayed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus.
    Albano L; Berthoux F; Moal MC; Rostaing L; Legendre C; Genin R; Toupance O; Moulin B; Merville P; Rerolle JP; Bayle F; Westeel PF; Glotz D; Kossari N; Lefrançois N; Charpentier B; Blanc AS; Di Giambattista F; Dantal J;
    Transplantation; 2009 Jul; 88(1):69-76. PubMed ID: 19584683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreas transplant outcomes for United States (US) cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR).
    Gruessner AC; Sutherland DE
    Clin Transpl; 2008; ():45-56. PubMed ID: 19708445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The therapy of rejection.
    Lazarovits AI
    Clin Invest Med; 1989 Oct; 12(5):311-5. PubMed ID: 2689028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular effects of cyclosporine and oncogenesis: a new model.
    André N; Roquelaure B; Conrath J
    Med Hypotheses; 2004; 63(4):647-52. PubMed ID: 15325009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicology and adverse effects of drugs used for immunosuppression in organ transplantation.
    Philip AT; Gerson B
    Clin Lab Med; 1998 Dec; 18(4):755-65. PubMed ID: 9891613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The history and activities of transplantation in Turkey.
    Karakayali H; Haberal M
    Transplant Proc; 2005 Sep; 37(7):2905-8. PubMed ID: 16213257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin 7 receptor alpha as a potential therapeutic target in transplantation.
    Racapé M; Vanhove B; Soulillou JP; Brouard S
    Arch Immunol Ther Exp (Warsz); 2009; 57(4):253-61. PubMed ID: 19585222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contemporary lung transplantation: the UCLA experience.
    Sherman W; Rabkin D; Ross D; Ardehali A;
    Clin Transpl; 2008; ():163-70. PubMed ID: 19708455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of anti-HLA antibodies detected by Luminex: enhancing the interpretation of CDC-BXM and important post-transplantation monitoring tools.
    Eng HS; Bennett G; Bardy P; Coghlan P; Russ GR; Coates PT
    Hum Immunol; 2009 Aug; 70(8):595-9. PubMed ID: 19527759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.